PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT 05405.\', \'Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98105.\', \'Data Science Department, Faraday, Inc., Burlington, VT 05405.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.\', \'Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT 05405; Emily.bruce@med.uvm.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e211651811910.1073/pnas.2116518119
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 35058348
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
is ?:relation_isRelatedTo_publication of
?:title
  • Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer:RNA ratio for Delta and Epsilon vs. Alpha variants.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all